title: Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex.
abstract: Cyclo(His-Pro) (CHP) is a cyclic dipeptide that is ubiquitously distributed through the central nervous system, including striatum. Many biologic effects of CHP seem to be mediated through a dopaminergic mechanism. To further examine the mechanism of action of this peptide, we have studied effects of chronic CHP treatment on the properties of nigro-striatal dopaminergic neurons in rats. Chronic CHP administration elicited significant increase in both KD and Bmax of striatal mazindol-binding sites (labelling DA transporter complex), but no change in either D1- or D2-type DA receptors. Chronic treatment with DA uptake blockers (e.g., benztropine, GBR 12909, bupropion, and mazindol) also produced changes in striatal mazindol-binding sites that were similar to that of chronic CHP. Furthermore, CHP led to a dose-dependent inhibition of [3H]-DA uptake by striatal synaptosomes, reaching to maximal inhibition of uptake (30%) at CHP dosage of 10 nM. The dose-response curve for CHP inhibition of DA uptake, unlike DA uptake blockers that led to a total inhibition, was partial and V-shaped. Again unlike DA uptake blockers, CHP did not inhibit the binding of [3H]-mazindol to striatal membranes. On the basis of these data we hypothesize that while CHP may inhibit DA uptake by modifying mazindol-binding locus at DA transporter complex, its primary action may be at a site other than mazindol-binding site.
authors.affiliation: Laboratory of Neurosciences, Pennington Biomedical Research Center, Baton Rouge, LA.
authors.forename: H
authors.initials: H
authors.lastname: Ikegami
authors.forename: C
authors.initials: C
authors.lastname: Prasad
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001665:Binding Sites; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D008297:Male; D008454:Mazindol / Q000378:metabolism; D009479:Neuropeptides / Q000494:pharmacology*; D010456:Peptides, Cyclic / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects
chemical_list: D009479:Neuropeptides; D010456:Peptides, Cyclic; D010879:Piperazines; D011954:Receptors, Dopamine; D008454:Mazindol; C015924:histidyl-proline diketopiperazine; D004298:Dopamine